Tolerability and long-term disease control by IGHV mutation status among patients with CLL on ibrutinib arm of E1912
Journal Article
Overview
Link to Article
10.1182/bloodadvances.2024013474
authors
Shanafelt, T. D.
Wang, X. V.
Hanson, C. A.
Paietta, E.
O'Brien, S.
Barrientos, J.
Jelinek, D. F.
Braggio, E.
Leis, J. F.
Zhang, C. C.
Barr, P. M.
Cashen, A. F.
Mato, A. R.
Singh, A. K.
Mullane, M. P.
Little, R. F.
Erba, H.
Stone, R. M.
Litzow, M.
Tallman, M.
Kay, N. E.
publication date
2025
published in
Blood advances
Journal
Research
keywords
Adverse Effects
Drugs and Drug Therapy
Leukemia
Randomized Controlled Trials
Additional Document Info
volume
9
issue
1